News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
532,475 Results
Type
Article (11324)
Company Profile (184)
Press Release (520964)
Multimedia
Podcasts (9)
Webinars (9)
Section
Business (181291)
Career Advice (489)
Deals (27509)
Drug Delivery (22)
Drug Development (59038)
Employer Resources (28)
FDA (10325)
Job Trends (9667)
News (259673)
Policy (19554)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (710)
Accelerated approval (26)
ADA (28)
Adcomms (2)
Allergies (109)
Alliances (37366)
ALS (143)
Alzheimer's disease (1115)
Antibody-drug conjugate (ADC) (335)
Approvals (10927)
Artificial intelligence (405)
ASCO (199)
Autoimmune disease (255)
Automation (38)
Bankruptcy (267)
Best Places to Work (7690)
BIO (58)
BIOSECURE Act (14)
Biosimilars (122)
Biotechnology (130)
Bladder cancer (143)
Brain cancer (39)
Breast cancer (598)
Cancer (4272)
Cardiovascular disease (239)
Career advice (421)
Career pathing (6)
CAR-T (240)
CDC (2)
Celiac Disease (1)
Cell therapy (642)
Cervical cancer (42)
Clinical research (53409)
Collaboration (1553)
Compensation (1422)
Complete response letters (36)
COVID-19 (1005)
CRISPR (76)
C-suite (949)
Cystic fibrosis (113)
Data (6517)
Denatured (4)
Depression (115)
Dermatology (64)
Diabetes (409)
Diagnostics (4452)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (223)
Drug pricing (17)
Drug shortages (4)
Duchenne muscular dystrophy (173)
Earnings (76134)
Editorial (9)
Employer branding (2)
Employer resources (29)
Events (96722)
Executive appointments (867)
FDA (13180)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (27)
Funding (1203)
Gene editing (152)
Generative AI (27)
Gene therapy (429)
GLP-1 (402)
Government (1177)
Grass and pollen (2)
Guidances (292)
Healthcare (9958)
Hematology (114)
HIV (56)
Huntington's disease (31)
IgA nephropathy (77)
Immunology and inflammation (114)
Immuno-oncology (71)
Indications (165)
Infectious disease (1219)
Inflammatory bowel disease (151)
Inflation Reduction Act (5)
Influenza (104)
Intellectual property (273)
Interviews (56)
IPO (13219)
IRA (6)
Job creations (2355)
Job search strategy (394)
JPM (4)
Kidney cancer (14)
Labor market (18)
Layoffs (96)
Leadership (3)
Legal (5467)
Liver cancer (55)
Longevity (24)
Lung cancer (551)
Lymphoma (326)
Machine learning (37)
Management (7)
Manufacturing (670)
Marketing (6)
MASH (130)
Medical device (8830)
Medtech (8951)
Mergers & acquisitions (15382)
Metabolic disorders (875)
mRNA (79)
Multiple sclerosis (140)
NASH (5)
Neurodegenerative disease (263)
Neuropsychiatric disorders (47)
Neuroscience (2129)
Neurotech (1)
NextGen: Class of 2026 (3550)
Non-profit (1067)
Now hiring (6)
Obesity (312)
Opinion (56)
Ovarian cancer (182)
Pain (189)
Pancreatic cancer (249)
Parkinson's disease (260)
Partnered (14)
Patents (510)
Patient recruitment (583)
Peanut (35)
People (46331)
Pharmaceutical (33)
Pharmacy benefit managers (9)
Phase 1 (17537)
Phase 2 (24009)
Phase 3 (15941)
Pipeline (7525)
Policy (53)
Postmarket research (1655)
Preclinical (7485)
Press Release (64)
Prostate cancer (208)
Psychedelics (9)
Radiopharmaceuticals (210)
Rare diseases (668)
Real estate (3773)
Recruiting (15)
Regulatory (16301)
Reports (22)
Research institute (791)
Resumes & cover letters (64)
Rett syndrome (42)
RNA editing (9)
RSV (50)
Schizophrenia (108)
Series A (218)
Series B (160)
Service/supplier (4)
Sickle cell disease (84)
Special edition (3)
Spinal muscular atrophy (108)
Sponsored (9)
Startups (2473)
State (1)
Stomach cancer (5)
Supply chain (62)
Tariffs (10)
The Weekly (5)
Vaccines (383)
Venture capital (35)
Weight loss (115)
Women's health (84)
Worklife (2)
Date
Today (72)
Last 7 days (304)
Last 30 days (1352)
Last 365 days (22134)
2026 (12349)
2025 (22146)
2024 (25863)
2023 (29718)
2022 (38261)
2021 (40675)
2020 (36515)
2019 (25894)
2018 (19600)
2017 (21270)
2016 (20385)
2015 (26590)
2014 (23472)
2013 (19899)
2012 (22046)
2011 (22401)
2010 (21997)
Location
Africa (340)
Alabama (75)
Alaska (2)
Arizona (301)
Arkansas (12)
Asia (22973)
Australia (3663)
California (12369)
Canada (3286)
China (793)
Colorado (484)
Connecticut (440)
Delaware (240)
Europe (39865)
Florida (1820)
Georgia (380)
Hawaii (3)
Idaho (50)
Illinois (759)
India (59)
Indiana (490)
Iowa (15)
Japan (423)
Kansas (107)
Kentucky (34)
Louisiana (26)
Maine (27)
Maryland (1272)
Massachusetts (8559)
Michigan (307)
Minnesota (562)
Mississippi (5)
Missouri (80)
Montana (29)
Nebraska (11)
Nevada (129)
New Hampshire (67)
New Jersey (2741)
New Mexico (17)
New York (2975)
North Carolina (1366)
North Dakota (8)
Northern California (6249)
Ohio (286)
Oklahoma (14)
Oregon (19)
Pennsylvania (2390)
Puerto Rico (23)
Rhode Island (33)
South America (541)
South Carolina (77)
South Dakota (1)
Southern California (5031)
Tennessee (116)
Texas (1943)
United States (40936)
Utah (368)
Vermont (1)
Virginia (163)
Washington D.C. (43)
Washington State (1002)
West Virginia (2)
Wisconsin (85)
532,475 Results for "refuge biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxart to Participate in BTIG Biotechnology Conference 2026
July 21, 2026
·
1 min read
Press Releases
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
June 17, 2026
·
11 min read
Business
Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene Expression Platform for Blood Cancers
Kite, a Gilead Company (Nasdaq: GILD) and Refuge Biotechnologies, Inc. (“Refuge”), today announced that Kite has entered into an exclusive, worldwide license agreement with Refuge, a synthetic biology company for cancer immunotherapy, for exclusive rights to utilize Refuge’s proprietary gene expression platform to develop potential treatments for blood cancers.
October 20, 2022
·
5 min read
Press Releases
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering - June 15, 2026
June 15, 2026
·
9 min read
Press Releases
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO
July 14, 2026
·
3 min read
Press Releases
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
July 21, 2026
·
3 min read
Press Releases
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
July 15, 2026
·
5 min read
Press Releases
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
July 8, 2026
·
1 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
July 17, 2026
·
4 min read
Press Releases
Riyadh Global Medical Biotechnology Summit Announces Scientific Program for 2026 Edition
International experts from leading universities, global biopharmaceutical companies, and investment organizations will convene in Riyadh, Saudi Arabia, September 14–16, 2026, for the fourth edition of RGMBS.
June 30, 2026
·
1 min read
1 of 53,248
Next
